Evidence map›Paper›PMID 38917794›Full record

ArticleMolecular cell2024

Genome-scale exon perturbation screens uncover exons critical for cell fitness.

Mei-Sheng Xiao, Arun Prasath Damodaran, Bandana Kumari, Ethan Dickson, Kun Xing, Tyler A On, Nikhil Parab, Helen E King, Alexendar R Perez, Wilfried M Guiblet and 8 more

Abstract read
In one paragraph

Article in Molecular cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Intron Retention Controls Localization of lncRNAsbioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Orthrus: Towards Evolutionary and Functional RNA Foundation Models.bioRxiv : the preprint server for biology · 2025
    Article
  12. mtKO: A dedicated guide RNA library for mitochondria research.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. A Manual for Genome and Transcriptome Engineering.IEEE reviews in biomedical engineering · 2025
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mei-Sheng XiaoRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Arun Prasath DamodaranRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: arunprasath.damodaran@nih.gov.
Bandana KumariRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Ethan DicksonRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Kun XingRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Tyler A OnMolecular Targets Program, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Nikhil ParabRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Helen E KingEMBL Australia and Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
Alexendar R PerezLaboratory of Biochemistry and Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA; Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA 94143, USA.
Wilfried M GuibletRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA.
Gerard DuncanProtein Characterization Laboratory, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21701, USA.
Anney CheAdvanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21701, USA.
Raj ChariGenome Modification Core, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21702, USA.
Thorkell AndressonProtein Characterization Laboratory, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21701, USA.
Joana A VidigalLaboratory of Biochemistry and Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Robert J WeatherittEMBL Australia and Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2010, Australia.
Michael AreggerMolecular Targets Program, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: michael.aregger@nih.gov.
Thomas Gonatopoulos-PournatzisRNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA. Electronic address: thomas.gonatopoulos@nih.gov.

Funding

Map Novel Regulatory Networks that Control Alternative SplicingZIABC012019 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONATOPOULOS-POURNATZIS, THOMAS · 2020 to 2025
$4.5M
Systematic Identification and Functional Characterization of Alternatively Spliced Exons with Phenotypic RelevanceZIABC012033 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONATOPOULOS-POURNATZIS, THOMAS · 2021 to 2025
$3.8M
Promoting Multidisciplinary Clinical and Translational Science in Aging by Resident InvestigatorsR38AG070171 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alison Huang, Ashwin Ajit Kotwal · 2021 to 2026
$1.8M
Improving editing efficiency and guide design of CHyMErA screening platformZIABC012102 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI AREGGER, MICHAEL · 2022 to 2025
$1.7M
CRISPR tools to dissect the coding and non-coding genomeZIABC011811 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI VIDIGAL, JOANA · 2018 to 2025
$1.7M
Intramural NIH HHS ZIA BC012033Intramural NIH HHS ZIA BC012102NIA NIH HHS R38 AG070171
6 · The paper itself

Abstract

CRISPR-Cas technology has transformed functional genomics, yet understanding of how individual exons differentially shape cellular phenotypes remains limited. Here, we optimized and conducted massively parallel exon deletion and splice-site mutation screens in human cell lines to identify exons that regulate cellular fitness. Fitness-promoting exons are prevalent in essential and highly expressed genes and commonly overlap with protein domains and interaction interfaces. Conversely, fitness-suppressing exons are enriched in nonessential genes, exhibiting lower inclusion levels, and overlap with intrinsically disordered regions and disease-associated mutations. In-depth mechanistic investigation of the screen-hit TAF5 alternative exon-8 revealed that its inclusion is required for assembly of the TFIID general transcription initiation complex, thereby regulating global gene expression output. Collectively, our orthogonal exon perturbation screens established a comprehensive repository of phenotypically important exons and uncovered regulatory mechanisms governing cellular fitness and gene expression.

Indexed as

ExonsAlternative SplicingCRISPR-Cas SystemsGene Expression RegulationGenetic FitnessHEK293 CellsHumansMutationRNA Splice SitesTATA-Binding Protein Associated FactorsTranscription Factor TFIIDRNA Splice SitesTATA-Binding Protein Associated FactorsTranscription Factor TFIIDalternative splicingbase editorCas12acell fitness exonsCRISPR screenexon deletionexon perturbationfunctional genomicsTAF5TFIID

Identifiers

PMID38917794
PMCPMC11246229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.